Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
40.8M
-
Shares change
-
-1.55M
-
Total reported value, excl. options
-
$621M
-
Value change
-
-$33.7M
-
Number of buys
-
39
-
Number of sells
-
-43
-
Price
-
$15.22
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q1 2020
101 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q1 2020.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.8M shares
of 63.6M outstanding shares and own 64.15% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5.42M shares), NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (4.32M shares), PRIMECAP MANAGEMENT CO/CA/ (3.54M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.03M shares), BAKER BROS. ADVISORS LP (2.71M shares), WELLINGTON MANAGEMENT GROUP LLP (2.67M shares), BlackRock Inc. (2.5M shares), MPM ASSET MANAGEMENT LLC (2.36M shares), and FEDERATED HERMES, INC. (2.27M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.